Skip to main content

Fennec Pharmaceuticals Inc(FRX-T)
TSX

Today's Change
Real-Time Last Update

Stocks in play: Fennec Pharmaceuticals Inc.

Baystreet - Fri Nov 11, 2022

Reported its financial results for the fiscal quarter ended September 30. Net loss for the three months was $8.1 million ($0.31 per share), compared to $4.2 million ($0.16 per share) for the same period in 2021. Fennec Pharmaceuticals Inc. shares T.FRX are trading un at $10.85.

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

watchlist
25 stocks most added to Watchlists